-logo.jpg "Microhealth (digital hematology)"){kind=logo}
New York, United States
MicroHealth, a digital health startup founded in 2015, focuses on transforming the way hematology care is provided by leveraging technology. The company's slogan, "Digital health platform to track, predict and prevent blood disease," highlights its commitment to a proactive approach in managing blood disorders.
Born out of collaboration between a patient and a medical researcher at Columbia University, MicroHealth has positioned itself as the world's leading digital hematology platform. Its impact is evident, with over 33% of United States hemophilia patients and healthcare professionals actively participating as MicroHealth members.
The company is headquartered in the United States and operates primarily within the Health Care and Sports industries. Notably, MicroHealth attracted early-stage investment interest, securing a $120.00K Seed Round investment from prestigious accelerator Y Combinator on 18 August 2015.
Investors looking to support disruptive healthcare technologies should consider the potential and scaling opportunity offered by MicroHealth.
